Sopheon PLC
20 June 2001
FOR IMMEDIATE RELEASE 20 June 2001
SOPHEON PLC
ISSUE OF CONVERTIBLE LOAN STOCK
Sopheon plc ('Sopheon' or 'the Company') announces that it has yesterday
issued £2.6 million of convertible unsecured loan stock ('the Loan Stock') to
a group of investors including key members of the Board and the senior
management team. The Loan Stock is convertible into ordinary shares in the
share capital of the Company.
Chairman Barry Mence said:
'I am delighted that the board and management team, together with a number of
external investors, have demonstrated their confidence in the future of
Sopheon. We are continuing the process of integrating the recently combined
organisation, positioning it for growth in the second half of this year and
strengthening the balance sheet, as stated at the time of our preliminary
results announcement in March. We remain on track with our proposed German
acquisition. Accolade, our first product combining the strengths of our entire
group, is being well received by the market as companies continue to look for
competitive advantage in the face of widespread and challenging economic
conditions.'
Of the total investment of £2.6m, members of the Board and senior management
have subscribed for £750,000. Details of the investment are as follows:
Name Value subscribed
£'000
Barry Mence, Chairman 390
Andrew Michuda, Chief Executive Officer 28
Arif Karimjee, Chief Financial Officer 17
Stuart Silcock, Non-Executive Director 100
Bernard Al, Non-Executive Director 25
Other Senior Management 190
External Investors 1,850
Total 2,600
The Loan Stock has the following principal terms:
* The Loan Stock carries an annual coupon rate of 6%. Investors have
been granted detachable warrants over ordinary shares of 5p each ('the
Warrants') equivalent to 15% of their Loan Stock value. In addition, at any
time up to 31 December 2001, investors may subscribe for an additional one
third of their initial Loan Stock value with a conversion price set at a 30%
premium to the initial Conversion Price, as defined below ('the Call Option').
Any further Loan Stock issued under the Call Option will have the same terms
as the Loan Stock including rights to Warrants with a subscription price at a
30% premium to the subscription price as defined below.
* The conversion price for the Loan Stock ('the Conversion Price') and
the subscription price of the Warrants is £0.70 being the average of the
mid-market close of the last ten trading days on the Alternative Investment
Market of the London Stock Exchange. This represents a premium of 15% to the
mid-market close on 19 June 2001. Conversion of the Loan Stock and exercise
of the Warrants are at the option of the investor between 12 and 24 months
from date of issue of the Loan Stock or earlier if the Company undertakes a
placing or similar equity issue. Any portion of the Loan Stock which is not
converted will be redeemed at par on 20 June 2003.
* If at any time after the date of issue of the Loan Stock and before
the date of conversion, the Company undertakes a placing or similar equity
issue ('the Placing') at a lower price ('the Placing Price'), the Conversion
Price for the Loan Stock will be adjusted to the Placing Price, to put
Investors in a position as if the Loan Stock had been issued concurrent with
the Placing. The subscription price for the Warrants will not be affected.
* All ordinary shares issued in relation to the Loan Stock, the
Warrants or any Call Option are subject to lock-in arrangements, with certain
exemptions, for the first six months after issue. Thereafter a maximum of 50%
of each issue of ordinary shares can become available for sale in each
successive six month period after issue. Thereafter, the parties have agreed
to be bound by orderly market restrictions.
For further information contact :
Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483-883000
Arif Karimjee, CFO Sopheon plc Tel : + 44 (0) 1483-883000
Steve Liebmann Buchanan Communications Tel : + 44 (0) 207-466-5000
Barbara Jansen Citigate First Financial Tel : + 31 (0) 205-754-080
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.